Senior Principal Scientist
Merck
Adrian Goodey is a Senior Principal Scientist in the Analytical Research & Development group within Merck Research Laboratories. In this role, Dr. Goodey has led development teams for a wide range of drug products including solid-oral, inhalers, nasal sprays and long-acting polymeric implants. Prior to joining the pharmaceutical industry in 2007 with Schering-Plough, Dr. Goodey earned a B.Sc. in chemistry from Emory University, completed a PhD in chemistry from the University of Texas at Austin, and then served as an ACS/PRF Alternative Energy Postdoctoral Fellow at the Pennsylvania State University. Dr. Goodey currently chairs the IPAC-RS Cascade Impaction working group and serves on the McMaster University Aerosol School faculty. His research interests include clinically relevant performance characterization and driving the science and regulation of complex dosage forms. To date, he has authored more than 20 articles and two patents.
Hot Topic: Regulatory Challenges and Considerations for Orally Inhaled Drug Product
Tuesday, October 24, 2023
10:00 AM – 11:00 AM ET